Considerations for using ETEC and Shigella disease burden estimates to guide vaccine development strategy. (2019)
Attributed to:
Epidemiological and statistical research on health problems of developing countries: MRC Tropical Epidemiology Group
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2017.09.083
PubMed Identifier: 29031690
Publication URI: http://europepmc.org/abstract/MED/29031690
Type: Journal Article/Review
Volume: 37
Parent Publication: Vaccine
Issue: 50
ISSN: 0264-410X